Virtual Reality (VR) Could Be a Good Alternative to Relaxing or Pain-relieving Medication
Launched by PETHER JILDENSTAL · Oct 17, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether Virtual Reality (VR) can be a helpful alternative to medications that relax or relieve pain for older adults who are having surgery with local anesthesia. The goal is to see if using VR can help reduce anxiety during these procedures, making the experience more comfortable for patients.
To be eligible for this study, participants need to be at least 65 years old and scheduled for surgery that will be done with local or regional anesthesia. However, individuals with dementia or significant cognitive impairments won't be able to participate. If you join the trial, you can expect to use VR technology during your surgery to help distract you and ease any feelings of anxiety. Overall, this study aims to find a new, non-drug approach to help older patients feel calmer during surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • over 65 years, planed surgery in local anesthesia/regional anesthesia
- Exclusion Criteria:
- • dementia, unable to cooperate, cognitive impairment
About Pether Jildenstal
Pether Jildenstal is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative trial design and execution. With a focus on rigorous scientific methodology and ethical standards, the organization collaborates with healthcare professionals, research institutions, and regulatory bodies to facilitate the development of novel therapies. Pether Jildenstal emphasizes transparency, data integrity, and patient safety, striving to deliver meaningful results that contribute to the enhancement of healthcare practices and the overall well-being of communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alingsås, Västra Götaland, Sweden
Göteborg, Västra Götaland, Sweden
Alingsås, , Sweden
Göteborg, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported